Acid-base metabolism: implications for kidney stosne formation

被引:28
作者
Hess, B [1 ]
机构
[1] Klin Pk, CH-8038 Zurich, Switzerland
来源
UROLOGICAL RESEARCH | 2006年 / 34卷 / 02期
关键词
urolithiasis; stone formation; acid-base metabolism; distal renal tubular acidosis; low urine pH and uric acid stones; metabolic syndrome and uric acid stones;
D O I
10.1007/s00240-005-0026-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The physiology and pathophysiology of renal H+ ion excretion and urinary buffer systems are reviewed. The main focus is on the two major conditions related to acid - base metabolism that cause kidney stone formation, i. e., distal renal tubular acidosis (dRTA) and abnormally low urine pH with subsequent uric acid stone formation. Both the entities can be seen on the background of disturbances of the major urinary buffer system, NH3 + H+ <-> NH4+ . On the one hand, reduced distal tubular secretion of H+ ions results in an abnormally high urinary pH and either incomplete or complete dRTA. On the other hand, reduced production/availability of NH4+ is the cause of an abnormally low urinary pH, which predisposes to uric acid stone formation. Most recent research indicates that the latter abnormality may be a renal manifestation of the increasingly prevalent metabolic syndrome. Despite opposite deviations from normal urinary pH values, both the dRTA and uric acid stone formation due to low urinary pH require the same treatment, i. e., alkali. In the dRTA, alkali is needed for improving the body's buffer capacity, whereas the goal of alkali treatment in uric acid stone formers is to increase the urinary pH to 6.2-6.8 in order to minimize uric acid crystallization.
引用
收藏
页码:134 / 138
页数:5
相关论文
共 19 条
  • [1] The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance
    Abate, N
    Chandalia, M
    Cabo-Chan, AV
    Moe, OW
    Sakhaee, K
    [J]. KIDNEY INTERNATIONAL, 2004, 65 (02) : 386 - 392
  • [2] URIC-ACID SATURATION IN CALCIUM NEPHROLITHIASIS
    COE, FL
    STRAUSS, AL
    TEMBE, V
    DUN, SL
    [J]. KIDNEY INTERNATIONAL, 1980, 17 (05) : 662 - 668
  • [3] DEFRONZO RA, 1979, AM J PHYSIOL, V233, pE214
  • [4] DUBOSE TD, 2004, BRENNER RECTORS KIDN, V1, pCH20
  • [5] CALCIUM-OXALATE STONE AGGLOMERATION REFLECTS STONE-FORMING ACTIVITY - CITRATE INHIBITION DEPENDS ON MACROMOLECULES LARGER THAN 30 KILODALTON
    ERWIN, DT
    KOK, DJ
    ALAM, J
    VAUGHN, J
    COKER, O
    CARRIERE, BT
    LINDBERG, J
    HUSSERL, FE
    FUSELIER, H
    COLE, FE
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (06) : 893 - 900
  • [6] Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey
    Ford, ES
    Giles, WH
    Dietz, WH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03): : 356 - 359
  • [7] Pathophysiology of hypocitf aturic nephrolithiasis
    Hamm, LL
    Hering-Smith, KS
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2002, 31 (04) : 885 - +
  • [8] HAMM LL, 1996, KIDNEY STONES MED SU, pCH12
  • [9] RISK-FACTORS FOR LOW URINARY CITRATE IN CALCIUM NEPHROLITHIASIS - LOW VEGETABLE FIBER INTAKE AND LOW URINE VOLUME TO BE ADDED TO THE LIST
    HESS, B
    MICHEL, R
    TAKKINEN, R
    ACKERMANN, D
    JAEGER, P
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (06) : 642 - 649
  • [10] Citrate determines calcium oxalate crystallization kinetics and crystal morphology - studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former
    Hess, B
    Jordi, S
    Zipperle, L
    Ettinger, E
    Giovanoli, R
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (03) : 366 - 374